You just read:

ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the Treatment of Breast Cancer

News provided by

Menarini Ricerche

23 Sep, 2019, 08:00 BST